As Achaogen INC (AKAO) Valuation Rose, Holder First Midwest Bank Trust Division Has Cut Stake

June 21, 2018 - By Vivian Currie

Achaogen, Inc. (NASDAQ:AKAO) LogoInvestors sentiment decreased to 1.02 in 2018 Q1. Its down 0.30, from 1.32 in 2017Q4. It fall, as 17 investors sold AKAO shares while 28 reduced holdings. 22 funds opened positions while 24 raised stakes. 25.38 million shares or 14.67% less from 29.75 million shares in 2017Q4 were reported. Td Asset Mngmt Incorporated stated it has 0% in Achaogen, Inc. (NASDAQ:AKAO). Price T Rowe Md stated it has 1.01M shares or 0% of all its holdings. First Midwest Financial Bank Tru Division has 100,091 shares. Moreover, Wellington Mngmt Limited Liability Partnership has 0% invested in Achaogen, Inc. (NASDAQ:AKAO) for 40,414 shares. Royal State Bank Of Canada holds 55 shares. Us Bank & Trust De reported 4,809 shares. Bnp Paribas Arbitrage has invested 0% in Achaogen, Inc. (NASDAQ:AKAO). Credit Suisse Ag holds 0% or 33,373 shares in its portfolio. Rmb Cap Mgmt Llc holds 0.04% in Achaogen, Inc. (NASDAQ:AKAO) or 127,407 shares. Renaissance Tech Limited Com owns 423,800 shares. Granite Investment Prns Ltd Limited Liability Company stated it has 16,251 shares. Daiwa Securities Grp has 0% invested in Achaogen, Inc. (NASDAQ:AKAO) for 234 shares. Moreover, Axa has 0.03% invested in Achaogen, Inc. (NASDAQ:AKAO) for 615,139 shares. 1.52M are owned by Vanguard Gru. Deutsche Commercial Bank Ag stated it has 0% of its portfolio in Achaogen, Inc. (NASDAQ:AKAO).

Since January 3, 2018, it had 11 insider buys, and 6 insider sales for $29.59 million activity. DUGGAN ROBERT W bought $738,853 worth of stock or 65,000 shares. Schilke Tobin had sold 2,087 shares worth $24,940 on Monday, June 11. Wise Blake sold 1,640 shares worth $17,499. $13,679 worth of stock was sold by Swem Lee on Wednesday, February 21.

First Midwest Bank Trust Division decreased its stake in Achaogen Inc (AKAO) by 73.24% based on its latest 2018Q1 regulatory filing with the SEC. First Midwest Bank Trust Division sold 273,916 shares as the company’s stock rose 10.74% while stock markets declined. The institutional investor held 100,091 shares of the health care company at the end of 2018Q1, valued at $1.30 million, down from 374,007 at the end of the previous reported quarter. First Midwest Bank Trust Division who had been investing in Achaogen Inc for a number of months, seems to be less bullish one the $566.23M market cap company. The stock decreased 2.92% or $0.38 during the last trading session, reaching $12.64. About 737,620 shares traded. Achaogen, Inc. (NASDAQ:AKAO) has declined 48.54% since June 21, 2017 and is downtrending. It has underperformed by 61.11% the S&P500.

First Midwest Bank Trust Division, which manages about $725.39 million US Long portfolio, upped its stake in Ishares Tr (MTUM) by 38,599 shares to 57,492 shares, valued at $6.09M in 2018Q1, according to the filing.

Analysts await Achaogen, Inc. (NASDAQ:AKAO) to report earnings on August, 2. They expect $-0.92 earnings per share, down 17.95 % or $0.14 from last year’s $-0.78 per share. After $-0.98 actual earnings per share reported by Achaogen, Inc. for the previous quarter, Wall Street now forecasts -6.12 % EPS growth.

More notable recent Achaogen, Inc. (NASDAQ:AKAO) news were published by: Nasdaq.com which released: “Achaogen Highlights Multiple Plazomicin Presentations at ASM Microbe 2018 Annual Meeting” on June 11, 2018, also Seekingalpha.com with their article: “Key events next week – healthcare” published on June 01, 2018, Prnewswire.com published: “Growing Demand for Biotechnologies are Expected to Grow” on June 18, 2018. More interesting news about Achaogen, Inc. (NASDAQ:AKAO) were released by: Seekingalpha.com and their article: “Achaogen: Buy Before The June 25 PDUFA Date” published on May 24, 2018 as well as 247Wallst.com‘s news article titled: “Biopharma Companies to Watch This Week and for the Rest of June” with publication date: June 09, 2018.

Achaogen, Inc. (NASDAQ:AKAO) Ratings Coverage

Among 7 analysts covering Achaogen (NASDAQ:AKAO), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 86% are positive. Achaogen has $28.0 highest and $1600 lowest target. $21’s average target is 66.14% above currents $12.64 stock price. Achaogen had 8 analyst reports since January 2, 2018 according to SRatingsIntel. As per Wednesday, February 28, the company rating was maintained by Needham. The company was downgraded on Monday, May 7 by Guggenheim. The firm has “Buy” rating by Stifel Nicolaus given on Wednesday, February 28. Cowen & Co maintained the stock with “Buy” rating in Wednesday, May 2 report. The firm has “Buy” rating by Wedbush given on Wednesday, February 14. The firm earned “Buy” rating on Wednesday, February 28 by Mizuho. The firm earned “Buy” rating on Tuesday, January 2 by Cowen & Co.

Achaogen, Inc. (NASDAQ:AKAO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: